Rocket Pharmaceuticals (NASDAQ:RCKT – Get Free Report) had its price target lifted by stock analysts at Scotiabank from ...

Shares of Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT – Get Free Report) have been given an average rating of “Moderate Buy” by the twelve analysts that are currently covering the company, Marketbeat ...

Fintel reports that on March 12, 2025, BMO Capital initiated coverage of Rocket Pharmaceuticals (NasdaqGM:RCKT) with a ...

LONG BEACH, Calif.—Merline Saintil, a director at Rocket Lab USA, Inc. (NASDAQ:RKLB), has sold 50,000 shares of the company's common stock, according to a recent SEC filing.... LONG BEACH, Calif.

Rocket Lab USA, Inc. (Nasdaq: RKLB) (“Rocket Lab” or “the Company”), a global leader in launch services and space systems, today... Investing.com -- The S&P 500 closed slightly higher ...

On December 11, 2024, the Company completed a public offering of approximately 15.2 million shares of our common stock ... full lives. Rocket’s adeno-associated viral (AAV) vector-based ...

Illustration of a colorful rocket launching into a clear blue sky ... Learn more about royalty-free images or view FAQs related to stock illustrations and vectors.

Choose from Rocketship Blueprint stock illustrations from iStock. Find high-quality royalty-free vector images that you won't find anywhere else. Video Back Videos home Signature collection Essentials ...

Rocket Lab USA, Inc. (RKLB) shares were trading more than 5% higher after-hours following the company’s reported Q1 results, with... Rocket Lab USA, Inc. (RKLB) reported Q1 EPS of ($0.06), $0.02 worse ...

Rocket Lab USA, Inc. (RKLB) shares were trading more than 5% higher after-hours following the company’s reported Q1 results, with EPS of ($0.06) coming in worse than the consensus... Rocket Lab USA, ...

Rocket Lab USA has a jam-packed 2025 schedule filled with new launches as well as acquisitions. Check out why I'm initiating ...